Biomerica's Shares Gain As Its Colon Disease Screening Test Goes For Sale At Walmart Online - Biomerica (

Biomerica Inc (NASDAQ:BMRA) has entered into a Supplier Agreement with Walmart Inc (NYSE:WMT) to sell its EZ Detect colorectal disease screening test within the Walmart retail system.
Beginning this week, Walmart has started selling the product through its online sales channel.
Biomerica is also in the final phase of working with Walmart to stock and sell the EZ Detect product on the shelf in their stores.
In addition, the Company is in negotiations with several large partners to distribute the EZ Detect product in Asia, Europe, and the Middle East.
The EZ Detect colon disease screening test is an at-home test to detect occult (hidden) blood in a person's stool, which can be an early warning sign of colorectal diseases, including colon and rectal cancers.
EZ Detect does not require handling of the stool, is simple to perform and provides results in just two minutes.
Price Action: BMRA stock is up 37.60% at $6.19 during the premarket session on the last check Friday.

To add Benzinga News as your preferred source on Google, click here.